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Abstract 
 
As therapeutic proteins become increasingly important in medical research and 
pharmaceutical use, it is useful to understand the optimal conditions to facilitate 
crystallization, the most stable form for protein storage.  The trial-and-error method is 
commonly used, but can be costly.  Crystallization is dependent on the protein’s 
interactions with itself and other components, and these interactions can be characterized 
by the second virial coefficient.  This value can be experimentally determined and used to 
predict crystallization conditions, in a more systematic and cost-effective way.  In this 
study, the interactions of the protein bovine chymotrypsinogen-A are studied with respect 
to the addition of polyethylene glycol (PEG), a polymer commonly used to stabilize 
therapeutic proteins.   This study indicates a slight repulsive interaction between 
chymotrypsinogen-A and polyethylene glycol, and shows signs of the depletion effect of 
PEG, the presence of which causes the chymotrypsinogen-A to interact more strongly 
with itself.   
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INTRODUCTION 
 
1.  Protein Crystallization 
Historically, the costliest steps in producing proteins have been separation and 
purification, especially at the high purities required for pharmaceutical use.  As of 2005, 
there were 230 biotechnology medicines and products on the market, with approximately 
20 drugs approved a year.
1
  In recent years, the global market for protein drugs has 
reached over $40 billion,
2
 and more than 400 proteins are approved for clinical trials 
yearly, about half of which are monoclonal antibodies.  In addition, the production of 
non-therapeutic proteins has a different set of process requirements
3
 and product 
specifications, such as larger production quantities and more flexible purity  
specifications.   
 
There are several factors that determine the approaches used to design protein separation 
processes.
3,4
  The design methods for therapeutic applications are governed by four 
factors: small production scales, regulatory oversight, lower importance of manufacturing 
costs compared to those of clinical trials, and prompt process development. Many 
processes are designed through trial-and-error, often using results based on extrapolating 
from small-scale experiments, and different companies tend to use their own conventions 
when selecting their process operations, which may result in time-constrained 
inefficiencies.  Monoclonal antibodies, which are increasingly being used and tested for 
pharmaceutical applications, also make use of similar approaches
4,5 
for downstream 
2 
 
processing.  As proteins are required on larger scales, and since manufacturing costs 
make up a large fraction of bulk protein production costs, a systematic process design 
method that creates a basis for initial product development could greatly benefit the US 
pharmaceutical industry.  By bringing the design of protein separations to the same level 
of more mature chemical processes, we will advance both the large-scale high-purity 
separations required for non-therapeutic protein production, and process design methods 
applied prior to FDA certification that can improve product and process development for 
therapeutic applications.   
 
The focus of this research project will be a specific bioseparations process development 
challenge: the bulk crystallization of proteins.  Pharmaceutical proteins used in many 
therapeutic and non-therapeutic applications must meet certain stability conditions, 
including a long shelf life, even though proteins, in general, are less stable than the small 
organic molecules commonly used in such applications.
6
  Since protein crystals are more 
stable than proteins in solution,
7
 one approach to achieving long-term stability is to use 
crystallized proteins.   
 
Proteins in aqueous solution can either precipitate or crystallize depending on the solution 
conditions, including pH, ionic strength, additives, temperature, and pressure.  In addition, 
crystallization can lead to the formation of various types of crystals depending on the 
conditions.  In the case of lysozyme, Velev et al.
8 
observed absence of precipitation or 
crystallization, partial precipitation, compact crystals, and needle-like crystals, depending 
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on solution conditions.  By altering conditions, such as acidity or ionic strength, or by 
adding different co-solvents to the solution, the protein-protein interactions can be 
modified, which, in turn, will affect the crystallization behavior.   
 
2.  Protein Interactions 
Protein-protein interactions are quantified by the second osmotic virial coefficient, Bii, 
which is the coefficient of the second term in the virial expansion of the equation for 
osmotic pressure, given below.   
𝛽𝛱 =  
𝑐𝑖
𝑀𝑖
+ 𝐵𝑖𝑖𝑐𝑖
2 + …          (1) 
where Π is the osmotic pressure,  is the inverse of the thermal energy (product of the 
ideal gas constant and temperature of the system), ci is the protein concentration, Mi is the 
protein molecular weight, and Bii is the osmotic second virial coefficient.  The osmotic 
pressure equation describes protein solution thermodynamics as deviations from ideal 
behavior, given by the first term on the right-hand side of equation (1).  The second and 
higher order terms in the virial expansion account for the deviations from ideality.  The 
osmotic second virial coefficient is related to the potential of mean force between two 
protein molecules in solution, and includes the effects of direct interactions between the 
two proteins, as well as indirect interactions through other protein molecules and the 
aqueous solution, including additives, such as polymers or salts.
9
  If the protein-protein 
potential of mean force is attractive, Bii is negative and the osmotic pressure is less than 
that for an ideal solution, while positive Bii values correspond to repulsive potentials of 
mean force,
10
 which lead to higher-than-ideal osmotic pressures.   
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According to the pioneering study done by George and Wilson
11
 in 1994, proteins only 
crystallize in a small crystallization window of slightly negative osmotic second virial 
coefficients, or where protein-protein interactions are slightly attractive.  For values of 
the osmotic second virial coefficient above (more positive than) the crystallization 
window, protein-protein interactions are repulsive, and the protein will remain in solution.  
For values of the osmotic second virial coefficient below (more negative than) the 
crystallization window, attractive protein-protein interactions dominate, and the protein 
will precipitate to form aggregates, rather than crystals.  The osmotic second virial 
coefficient can be measured to predict the solution conditions designed to be within the 
crystallization window; identifying these conditions and how they can be achieved by 
adding alcohols and polyols is the focus of this thesis.   
 
3. Effects of Additives 
Only a few studies have been published on the effects of pH, ionic strength, and additives 
on a protein solution to determine their effects on protein crystallization.  In a 2005 study 
done by Asthagiri et al.,
12
 osmotic second virial coefficients for a lysozyme solution with 
no additives were measured as a function of the ionic strength.  From this study, higher 
ionic strengths were found to increase attractive protein-protein interactions, resulting in 
a lower second osmotic virial coefficient and a less soluble protein.  In another study, Liu 
et al.
13
 used light scattering measurements of the osmotic second virial coefficient to 
determine the effects of alcohol additives, which are known to increase protein stability, 
on lysozyme solution were explored.  In this case, it was found that adding alcohols 
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decreased protein-protein interactions, resulting in osmotic second virial coefficients that 
were more repulsive and enhanced lysozyme solubilities. 
 
The goal of this research project is to study the effect of adding polyethylene glycol to 
aqueous solutions containing bovine chymotrypsinogen-A.  Chymotrypsinogen is the 
inactive form of chymotrypsin, a pancreatic enzyme that is active toward the carboxyl 
groups of aromatic amino acids and catalyzes the cleavage of aromatic substances.
14
  
Chymotrypsinogen has a non-uniform surface charge that induces attractive electrostatic 
protein-protein interactions
8
.  Polyethylene glycol (PEG) is a polymer that is commonly 
used to stabilize protein solutions, either as a simple additive or by attaching the polymer 
to proteins to prolong lifetime and increase potency.
15
  In a 2002 study by Lu et al.,
16
 
PEG 4000 and PEG 1500 were reported to enhance chymotrypsinogen crystallization, or 
gelation at high concentrations of protein, indicating increased protein-protein attraction 
due to addition of PEG.   
 
For a system with two components, the osmotic pressure is modeled as in Equation 2, 
where c2 and M2 are the concentration and molecular weight of the first component, c3 
and M3 are the concentration and molecular weight of the second component, B22 and B33 
are the self-interaction coefficients of each component, and B23 is the cross-interaction 
coefficient,   
𝛽𝛱 =  
𝑐2
𝑀2
+
𝑐3
𝑀3
+ 𝐵22𝑐2
2 + 𝐵33𝑐3
2 + 2𝐵23𝑐2𝑐3 + ⋯   (2) 
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The cross-interaction coefficient is interpreted similarly to the osmotic second virial 
coefficient for a single component; a negative B23 reflects attractive intermolecular 
interactions between the two components, while a positive value reflects repulsive 
interactions.    
 
4. Measurement Techniques 
Several experimental techniques have recently been developed for measuring the cross-
interaction virial coefficient, including cross-interaction chromatography and static light 
scattering.  Cross-interaction chromatography is based on self-interaction 
chromatography and requires one component to be immobilized on to a chromatographic 
surface while the other component is eluted over it.  The retention volume, which is the 
amount required to elute the solute from the column,
17
 is measured in the 
chromatography process, and this value is used to calculate the retention factor.  The 
retention factor can then be related to the cross-interaction virial coefficient.  Several 
assumptions are made for cross-interaction chromatography with regards to the measured 
interactions; it is assumed that the eluting species only interacts with one immobilized 
particle at a time, and that the moving particles do not interact appreciably with each 
other.
18
  The first assumption is dependent on the spacing of the immobilized component, 
and the second is valid at low concentrations,
17
 which restricts this technique to a certain 
range of conditions.  In addition, it is assumed that the interactions are the same 
regardless of the immobilization of one component.   
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Static light scattering measures the amount of light scattered by both the proteins and 
PEG in solution.  The scattered light varies based on the distance between the molecules, 
and these distances change depending on the interactions between the particles.  
Traditional static light scattering is performed batchwise, and a separate sample must be 
made for every protein concentration.  The light scattering at a certain angle is measured 
at a set of concentrations, and the correlation between the scatter and concentration can 
be used to determine the second virial coefficient.   
 
The method used in this work is composition gradient static light scattering, which allows 
the samples to mix with a series of feed pumps, which can be controlled through a 
computer.  This greatly facilitates the process, as only one stock sample is required, and 
the process becomes continuous.  A schematic is given in Figure 1.   
 
 
 
 
UV detector LS detector 
A B C 
I 
D E F 
 G 
H 
Figure 1: Composition Gradient Static Light Scattering Schematic – A,B,C: protein 
solution, buffer, and wash reservoirs respectively; D,E,F: syringe pumps; G: mixer; H: 
membrane filter; I: Waste; Arrows indicate direction of flow. 
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It should be noted that the signals from the detectors are sent to a computer to be 
analyzed, and analysis occurs in the same way as batch-style static light scattering.  
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EXPERIMENTS 
 
1. Static Light Scattering Theory  
The light scattering instrument consists of a laser light source and a photomultiplier that 
measures the amount of scattered light at a specific angle.  From these measurements on a 
solution containing a single protein (no PEG), the osmotic second virial coefficient is 
obtained from the slope of a Zimm plot based on the following relation,   
 
𝐾𝑐1
𝑅
=
1
𝑀1
+ 2𝐵11𝑐1         (3) 
where c1 is the concentration of the sample, M1 is the protein molecular weight, K is an 
optical constant, and R is the excess Rayleigh ratio.  The optical constant is calculated as 
follows:  
𝐾 =
4𝜋2(𝑑𝑛 /𝑑𝑐 )2𝑛0
2
𝑁𝐴𝜆0
4          (4) 
where dn/dc is the refractive index increment of the sample, n0 is the refractive index of 
the solvent, NA is Avogadro’s number, and λ0 is the vacuum wavelength of the laser.  The 
excess Rayleigh ratio is the normalized scattering intensity, and given by the following 
equation for a specific scattering angle:  
𝑅 =  
𝐼𝐴𝑛0
2𝑅𝑇
𝐼𝑇𝑛𝑇2
          (5) 
Here, IA is the excess scattering intensity of the sample, n0 is the refractive index of the 
solvent, and RT, IT, and nT are the Rayleigh ratio, scattering intensity, and refractive index, 
respectively, of toluene, the reference scattering compound.   
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In the light scattering experiment, the excess scattering intensity is measured, and the 
Rayleigh ratio for that measurement is calculated based on the various input parameters.  
For a single protein in solution, the concentration of the protein is adjusted for each 
measurement, and the Rayleigh ratios computed at each protein concentration are plotted 
as a function of concentrations to obtain the Zimm plot.  The osmotic second virial 
coefficient and molecular weight of the protein are obtained from the slope and intercept 
respectively, of the so-obtained linear fit, as defined by equation (3).  An example of a 
Zimm plot is shown in Figure 2.   
 
Figure 2: Sample Zimm Plot 
When measuring an osmotic second virial cross-coefficient, two scattering species are 
present in solution, so light scattering from both will contribute to the Rayleigh ratio.  
Therefore, in this measurement, one component is held at a constant concentration, while 
the concentration of the other component is adjusted.  In our experiments, the polymer 
(component 2) is held constant as the protein (component 1) concentration is diluted.  As 
3.5
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shown by Bloustine et al.,
19
 the excess Rayleigh Ratio, (R1+2 – R2), for this two-
component system is given by:  
𝐾𝑐1
𝑅1+2  − 𝑅2
= 𝛼 +  𝛽𝑐1        (6) 
The excess Rayleigh ratio of the protein/polymer solution relative to the polymer solution 
is the measured quantity, and α and β depend on osmotic virial coefficients, molecular 
weights, and differential refractive indices:  
𝛼 =
1
𝑀1
+  4𝑚𝐵12𝑐2         (7) 
where B12 is the osmotic second virial cross-coefficient, and m is defined as: 
𝑚 =
𝑀2(𝑑𝑛 /𝑑𝑐 )2
𝑀1(𝑑𝑛 /𝑑𝑐 )1
         (8) 
and 
𝛽 = 2𝐵11 + 2[ 3𝐶112 − 2𝐵12
2 𝑀2 + 𝑚 3𝐶112 + 2𝐵11𝐵12𝑀1 ]𝑐2   (9) 
 
The data for each cross-interaction experiment corresponds to a single c2 and consists of  
a series of R and c1 measurements.  A Zimm plot is constructed from the data, based on 
equation (6), which yields α and β for that concentration c2.  The experiment is then 
repeated at different constant concentrations, c2, to give α and β values over a range of c2.  
The α and β are then plotted separately as functions of c2, and a linear fit is used to obtain 
the osmotic second virial cross-coefficient from the slope of the α plot, while the β plot is 
used to find the PEG concentration dependence for protein-protein self-interactions from 
the intercept.   
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2.  Materials and Methods 
Buffer components, bovine chymotrypsinogen-A, and PEG 8000 were all obtained from 
Sigma-Aldrich.  Glassware was washed thoroughly with 5% Contrad 70 detergent, and 
soaked overnight in 0.5% Helmammex solution.  Before use, glassware was rinsed with 
Barnstead nanopure water; all glassware used for protein or polymer solutions were also 
rinsed with buffer.  Experiments were completed entirely with bis-tris buffer at pH 7, and 
NaCl was used to set the ionic strength of the buffer to 0.1m (0.11M).  The buffer was 
then stirred and vacuum-filtered through a 0.10 micron PVDF filter.   
 
For the protein self-interaction experiment, a solution of 2 mg/mL bovine 
chymotrypsinogen-A in buffer was made at room temperature, shaken for 30 minutes, 
and filtered through a 0.10 micron syringe filter.  For the cross-interaction experiments, a 
PEG 8000 buffer stock was made at the required concentration for each experiment, then 
stirred and filtered with a 0.10 micron syringe filter.  A 10 mg/mL chymotrypsinogen 
solution was then made using the PEG 8000 buffer, with the same procedure as detailed 
above for the single-protein solution.  
 
Light scattering measurements were made with a Wyatt mini-Dawn TREOS at a 90° 
angle and concentrations were measured with a ProStar 325 UV detector from Varian, 
Inc.  After each experiment, the system was primed with a 200 ppm sodium azide and 30% 
methanol solution for 30 minutes, followed by 30 minutes of 2% Contrad 70, and then 
13 
 
with nanopure water.  A Rudolph Research J57 Autotmatic Refractometer, which was 
calibrated with nanopure water, was used to measure refractive indices.  
 
3.  Experimental Design 
The methods for the experiments were designed as follows.  In all experiments, two 
injections of pure protein solution were included in a row at the beginning of the 
experiment to account for adsorption of protein particles onto the system.  All replicates 
were randomized, and each protein injection was separated by two injections of buffer 
(PEG solution for cross-interaction experiments) to neutralize the system.   
 
For the chymotrypsinogen self-interaction experiment, the measurement concentrations 
were diluted to 10%, 12%, 14%, 16%, 18%, and 20% protein for three replicates, and to 
40%, 60%, 80%, and 100% protein for two replicates.  The method is shown in Figure 3 
below, with blue peaks indicating concentrations of protein at set times.   
 
Figure 3: Self-Interaction Method 
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For the cross-interaction experiments, chymotrypsinogen concentrations of 10%, 20%, 
30%, 50%, 70%, and 90% mg/mL were used, with three replicates each.  The cross-
interaction experiment was repeated at PEG concentrations of 10, 20, 30, and 40 mg/mL.  
An example of a cross-interaction experiment method is shown in Figure 4.  The method 
was randomized in a different order for each concentration of PEG used.   
 
Figure 4: Cross-Interaction Sample Method 
In addition, an experiment was completed to measure the differential refractive index of 
PEG 8000.  Measurements of refractive index were taken at concentrations of 0, 10, 20, 
30, 40, 50, and 60 mg/mL PEG 8000.   
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RESULTS AND DISCUSSION 
 
1.  Light Scattering Analysis 
The results from the light scattering were observed as a set of data peaks similar to the 
method peaks.  Figure 5 gives an example of a close-up of a data peak, with the 
calibrated light scattering signal in blue and the concentration in black.   
 
Figure 5: Data Peak  
Using the Calypso software, a flat section of each peak was selected with the cursors, and 
the data were read from the immediate area, marked in grey.  The resulting data points 
were then exported to a text file to be plotted.   
 
2. Results 
In order to calculate the cross-interaction coefficient, the parameter m (equation 8) is 
required.  This parameter is a ratio of the molecular weights and differential refractive 
16 
 
indices of the two components.  The molecular weights are known: chymotrypsinogen is 
25670 Daltons and PEG is 8000 Daltons.  The differential refractive index, or dn/dc, of 
chymotrypsinogen is taken to be 0.192 mL/g from literature.
8
  The dn/dc of PEG 8000 
was calculated by taking measures of the refractive index at different concentrations of 
PEG.  The results are reported in Figure 6.  From this plot, the differential refractive 
index is found to be 0.1254 mL/g.  With these values, m is calculated to be 0.2035.   
 
 
 
Figure 6: dn/dc of PEG 8000 
 
For each protein concentration, the mean of the replicate measurements was used for the 
Zimm plot.  The mean protein concentration at 10% dilution was used to calculate the 
real concentration of the stock solution.  Values for all concentrations above 1 mg/mL 
were obtained based on the calculated stock solution concentration.  It should be noted 
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that the UV detector could measure protein concentrations up through 2 mg/mL, but all 
protein concentrations above 1 mg/mL were recalculated based on the stock solution 
concentration for consistency.   
 
Systematic deviation in the excess Rayleigh ratios was observed on the Zimm plot at both 
high and low protein concentrations.  These deviations are thought to be due to intrinsic 
limitations of the light scattering instrument at both high and low concentrations. 
Therefore, in the linear fits of the data, the highest protein concentration was removed, 
and only the median values of multiple measurements were used at the lowest 
concentration.  The final result is shown in Figure 7.   
 
 
Figure 7: Zimm Plot with c2 = 0 g/mL,  
M1 = 24144 g/mol, B11 = -0.00109/2 = -5.43 x 10
-4 mol.mL/g2 
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The linear fit gave an osmotic second virial coefficient of -5.43 x 10
-4
 mol.mL/g
2
 for 
chymotrypsinogen and a protein molecular weight of 24144 Daltons.  This molecular 
weight, rather than the literature value of 25670 Daltons, is used for 0 mg/mL PEG 
concentration in the determination of the osmotic second virial cross-coefficient for 
chymotrypsinogen and PEG.    
 
Zimm plots for the protein/PEG solutions at constant PEG concentration, plotted as a 
function of protein concentration, are given in Figures 8-11.   
 
 
Figure 8: Zimm plot with c2 = 0.01 g/mL,  
α = 20154 g/mol, β = -0.00133/2 = -6.63 x 10-4 mol.mL/g2 
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Figure 9: Zimm plot with c2 = 0.02 g/mL,  
α = 24287 g/mol, β = -0.00134/2 = -6.70 x 10-4 mol.mL/g2 
 
 
Figure 10: Zimm plot with c2 = 0.03 g/mL, 
α = 22617 g/mol, β = -0.00138/2 = -6.89 x 10-4 mol.mL/g2 
3.4
3.5
3.6
3.7
3.8
3.9
4
4.1
4.2
0 0.001 0.002 0.003 0.004 0.005 0.006
K
c 1
/R
 x
 1
0
5
(m
o
l/
g)
c1 (g/mL)
Kc1/R vs. c1
3.6
3.7
3.8
3.9
4
4.1
4.2
4.3
4.4
0 0.001 0.002 0.003 0.004 0.005 0.006
K
c 1
/R
 x
 1
0
5
(m
o
l/
g)
c1 (g/mL)
Kc1/R vs. c1
20 
 
 
Figure 11: Zimm plot with c2 = 0.04 g/mL, 
α = 19480 g/mol, β = -0.00079/2 = -3.95 x 10-4 mol.mL/g2 
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The values of α obtained from the Zimm plots are graphed as a function of PEG 
concentration, c2, in Figure 12.   
 
 
Figure 12: Plot of α as a function of PEG concentration 
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which gives a molecular weight of 24241 g/mol for the chymotrypsinogen, compared to 
the literature value of 25670 and an osmotic second virial cross-coefficient of 
𝐵12 =  2.35 × 10
−4 𝑚𝑜𝑙. 𝑚𝐿/𝑔2 . 
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The β-values obtained from the Zimm plots are graphed as a function of the PEG 
concentration, shown in Figure 13.   
 
 
Figure 13: Plot of β as a function of PEG concentration 
 
The intercept of this plot is twice the osmotic second virial coefficient for 
chymotrypsinogen in the absence of PEG (equation 9): -5.43 x 10
-4
 mol.mL/g
2
.  The 
slope gives the C112 = -5.46 x 10
-4
 mol.mL
2
/g
3
, which can be used to calculate the 
effective osmotic second virial coefficient for chymotrypsinogen in the presence of PEG 
(equation 10): 
𝐵11
𝑒𝑓𝑓
 = 𝐵11 + 𝑐2 3𝐶112 − 2𝐵12
2 𝑀2 .       (10) 
The concentration dependence of 𝐵11
𝑒𝑓𝑓
 is given by, 
𝜕𝐵11
𝑒𝑓𝑓
/𝜕𝑐2   = 3𝐶112 − 2𝐵12
2 𝑀2  =  −2.52 × 10
−3 𝑚𝑜𝑙. 𝑚𝐿2/𝑔3. 
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3. Discussion and Conclusions 
The second virial coefficient obtained in the self-interaction experiment, which was done 
at pH 7 and ionic strength 0.11M, is -5.43 x 10
-4
 mol.mL/g
2
.  This is comparable to the 
study done by Velev et al.
8
, wherein the second virial coefficient at pH 6.8 and ionic 
strength 0.1M was found with static light scattering to be -4.10 x 10
-4
 mol.mL/g
2
.  In the 
same study, the molecular weight was obtained to be 24450 Daltons from light scattering, 
and reports a literature value of 23660 and a calculated value of 25670 Daltons.  
Comparatively, the experimental molecular weight is 24144 Daltons, which is close to 
the value obtained in the Velev study.   
 
The cross-interaction coefficient is 2.35 x 10
-4
 mol.mL/g
2
, which shows an extremely 
slight positive interaction, indicating that the protein and polymer have little interaction 
beyond a small amount of repulsion.  Bloustine et al.
20
 report a value of 1.7 x 10
-4
 
mol.mL/g
2
 for the cross-interaction of PEG 8000 and lysozyme at pH 6.2 and ionic 
strength 0.5M.  Although their experiment is not completely comparable, due to the 
differences in buffer conditions and, more importantly, protein type, the general trend 
observed is similar.  The self-interaction of lysozyme at the conditions in the Bloustine 
paper is given as approximately -4 x 10
-4
 mol.mL/g
2
, or slightly self-attracting, and 
adding PEG 8000 to this protein causes a small positive cross-interaction.   
 
In addition, the concentration dependence of 𝐵11
𝑒𝑓𝑓
 is -2.52 x 10
-3
 mol.mL
2
/g
3
.  From the 
study by Bloustine et al.,
19
 when the concentration dependence is negative, PEG induces 
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attraction between the protein molecules.  This increased self-attraction is most likely due 
to depletion theory, which states that the addition of PEG increases protein self-attraction, 
as PEG promotes protein stability.  It should be noted that the Bloustine study found 
decreasing protein attraction when adding PEG 8000 to lysozyme.  Therefore, it can be 
theorized that the addition of PEG 8000 to a self-attractive protein causes the protein to 
become less self-attractive.   
 
In conclusion, this study has found a trend that adding PEG 8000 to chymotrypsinogen 
causes a slight amount of repulsion between the two components, and increases the 
chymotrypsinogen’s attraction to itself.  Based on the paper by Bloustine et al.19, it is 
suggested that the addition of PEG 8000 to slightly self-attractive proteins results in very 
minimal repulsive protein-polymer interactions.  Due to the large scattering present in the 
plots for α and β, it is recommended that the experiments be repeated to confirm the trend.    
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APPENDIX 
 
 
c2 (g/mL) n (refractive index) 
0 1.33557 
0.01 1.33675 
0.02 1.33796 
0.03 1.33923 
0.04 1.34053 
0.05 1.34177 
0.06 1.34307 
Table 1: dn/dc data 
 
 
 
 
 
 
 
 
c1 (g/mL) Kc1/R x 10
5
 (mol/g) 
0.001063 3.986449 
0.001215 4.062201 
0.003038 3.80077 
0.004556 3.633475 
0.006075 3.494005 
Table 2: Chymotrypsinogen Self-Interaction Data, PEG = 0 g/mL 
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c2 = 0.01 g/mL 
c1 (g/mL) Kc1/R x 10
5
 (mol/g) 
0.000717 4.957833 
0.001434 4.760175 
0.002151 4.580553 
0.003585 4.465066 
0.005019 4.30782 
0.006453 4.135572 
c2=0.02 g/mL 
0.00059 4.120225 
0.00118 3.954918 
0.00177 3.809855 
0.00295 3.668771 
0.00413 3.5729 
0.005309 3.445319 
c2=0.03 g/mL 
0.000614 4.365648 
0.001228 4.246441 
0.001842 4.162559 
0.00307 3.961732 
0.004299 3.822078 
0.005527 3.68558 
c2=0.04 g/mL 
0.000718 5.166866 
0.001436 4.99454 
0.002153 4.909591 
0.003589 4.786064 
0.005024 4.756665 
0.00646 4.657164 
Table 3: Data for Cross-Interaction Experiments 
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Table 4: α as a function of c2 
 
 
 
 
c2 (g/mL) β (mol.mL/g
2
) 
0 -0.00109 
0.01 -0.001325 
0.02 -0.001162 
0.03 -0.001378 
Table 5: β as a function of c2 
 
 
 
 
n2 
(mL/g) 
B11, 
(mol.mL/g
2
) 
M1, 
self interaction 
(g/mol) 
B12 
(mol.mL/g
2
) 
C112, 
(mol.mL
2
/g
3
) 
𝛛𝐁𝟏𝟏
𝐞𝐟𝐟/𝛛𝐜𝟐 
(mol.mL
2
/g
3
) 
0.1254 -5.43 x 10
-4
 24144 2.35 x 10
-4
 -5.46 x 10
-4
  -2.52 x 10
-3
 
Table 6: Summary of Results 
c2 (g/mL) α x 10
5
 (mol/g) 
0 3.90625 
0.01 4.9616 
0.02 4.1175 
0.03 4.4214 
0.04 5.1336 
